KRONOS BIO INC (KRON)

US50107A1043 - Common Stock

0.96  -0.05 (-4.95%)

After market: 1.0299 +0.07 (+7.28%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
6.29M0.000.000.000.00
Operating Expenses
125.22M137.12M151.40M58.04M16.82M
Research and Development
83.06M90.65M109.59M38.96M13.45M
Selling, General, and Administrative Expenses
42.16M46.47M41.80M19.07M3.37M
Operating Income
-118.93M-137.12M-151.40M-58.04M-16.82M
Interest Income/Expense
9.16M3.91M320.00K-30.40M700.00K
Non Recurring Items
-2.90MN/AN/AN/AN/A
Income Before Taxes
-112.67M-133.20M-151.08M-88.44M-16.12M
Net Income
-112.67M-133.20M-151.08M-88.44M-16.12M
EBITDA
-116.79M-134.85M-149.42M-57.20M-16.46M
 
Per Share Data
EPS Diluted Total Ops
-1.95-2.37-2.76-1.64-0.30
Non GAAP EPS
-1.86-2.37-2.75N/AN/A
 
Statistics
Profit Margin
-1791.87%N/AN/AN/AN/A
Operating Profit Margin
-1891.38%N/AN/AN/AN/A

All data in USD

Charts